
In a target trial emulation using N3C data, adults prescribed metformin within six days of SARS-CoV-2 infection had about half the risk of long COVID or death within six months.
Peter Hotez, MD, PhD, recently authored a paper proposing a federally directed but state-adaptive reopening that aims for acceptable national suppression by October 1.
Dr. Peter Hotez is a physician and researcher with experience in neglected tropical diseases and vaccine development.
Dr. Hotez recently authored a paper proposing a federally directed but state-adaptive reopening centered on the goal of acceptable containment of COVID-19 nationally by October.
Dr. Hotez is also involved in vaccine development efforts related to SARS-CoV-2. In the first part of our interview, Dr. Hotez explains the "October Plan" for reopening with a cohesive national strategy.






